More fusions & rearrangements precise diagnoses therapeutic targets answers for more patients.
Aventa tests use Arima Hi-C sequencing to detect and characterize clinically relevant fusions and rearrangements in routine FFPE tumor tissue. By providing genome-wide structural information that complements conventional testing, they can help resolve diagnostic questions and inform treatment decisions.
Aventa FusionPlus
For solid tumors that remain driver-negative after conventional profiling, Aventa FusionPlus can identify actionable fusions that may inform targeted therapy or clinical-trial consideration. It also characterizes rearrangements that can support diagnosis and classification in fusion-defined tumor types.
Actionable insights start here
Aventa Lymphoma
Aventa Lymphoma provides broad rearrangement profiling across 417 genes to help clarify B- and T-cell lymphoma diagnosis and classification, particularly when conventional testing leaves questions unresolved. The additional molecular evidence can help refine risk assessment and inform treatment decisions.
Ordering Aventa tests is easy
We handle specimen retrieval and return, and results are returned in about 10 business days.
We are committed to making our tests accessible and affordable
Aventa Assist offers programs to help patients whose costs for Aventa tests are not fully covered by insurance.